A gain in July home prices lifted the markets to a higher open with the Dow rising 60 points to 18,155. Nasdaq climbed 24 points to 5,281.
On the upside
Inventergy Global (Nasdaq: INVT) partner Pabellon has engaged with a Fortune 100 company to create a proof of concept to demonstrate its breakthrough Surface Plane Magnetic Technology to continuous charge remote internet devices.
Kite Pharma (Nasdaq: KITE) reported positive topline results from interim data of a ZUMA-1 trial of KTE-C19 in patients with aggressive non-Hodgkin lymphoma.
Boston Scientific (NYSE: BSX) will pay a premium of approximately $210 million in cash to acquire EndoChoice Holdings (NYSE: GI).
On the downside
Rice Energy (NYSE: RICE) priced its public offering of 40 million common shares at the discounted price of $25.50 per share.
Caesars Entertainment (Nasdaq: CZR) reached a restructuring agreement with its creditors.
Nektar Therapeutics (Nasdaq: NKTR) and Bristol-Myers Squibb (NYSE: BMY) will collaborate to evaluate Bristol-Myers Squibb's Opdivo with NKTR-214 as a potential combination treatment for cancer.
In the broad market, advancing issues outpaced decliners by a margin of 7 to 5 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 gained 6 points to 2,152. Bitcoin slipped $1 to $604.
